Information between 14th November 2024 - 4th December 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Division Votes |
---|
19 Nov 2024 - Passenger Railway Services (Public Ownership) Bill - View Vote Context Allison Gardner voted Aye - in line with the party majority and in line with the House One of 324 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 350 Noes - 108 |
27 Nov 2024 - Finance Bill - View Vote Context Allison Gardner voted Aye - in line with the party majority and in line with the House One of 319 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 176 |
27 Nov 2024 - Finance Bill - View Vote Context Allison Gardner voted No - in line with the party majority and in line with the House One of 320 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 112 Noes - 333 |
25 Nov 2024 - Non-Domestic Rating (Multipliers and Private Schools) Bill - View Vote Context Allison Gardner voted Aye - in line with the party majority and in line with the House One of 319 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 336 Noes - 175 |
25 Nov 2024 - Non-Domestic Rating (Multipliers and Private Schools) Bill - View Vote Context Allison Gardner voted No - in line with the party majority and in line with the House One of 320 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 173 Noes - 335 |
26 Nov 2024 - Tobacco and Vapes Bill - View Vote Context Allison Gardner voted Aye - in line with the party majority and in line with the House One of 317 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 415 Noes - 47 |
29 Nov 2024 - Terminally Ill Adults (End of Life) Bill - View Vote Context Allison Gardner voted No - against a party majority and against the House One of 147 Labour No votes vs 234 Labour Aye votes Tally: Ayes - 330 Noes - 275 |
3 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Allison Gardner voted Aye - in line with the party majority and in line with the House One of 324 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 332 Noes - 189 |
3 Dec 2024 - National Insurance Contributions (Secondary Class 1 Contributions) Bill - View Vote Context Allison Gardner voted No - in line with the party majority and in line with the House One of 322 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 186 Noes - 330 |
3 Dec 2024 - Elections (Proportional Representation) - View Vote Context Allison Gardner voted No - against a party majority - in line with the party majority and against the House One of 50 Labour No votes vs 59 Labour Aye votes Tally: Ayes - 138 Noes - 136 |
Speeches |
---|
Allison Gardner speeches from: Oral Answers to Questions
Allison Gardner contributed 1 speech (114 words) Monday 2nd December 2024 - Commons Chamber Ministry of Housing, Communities and Local Government |
Allison Gardner speeches from: Holidays in School Term Time
Allison Gardner contributed 1 speech (1,149 words) Monday 25th November 2024 - Westminster Hall Department for Education |
Allison Gardner speeches from: Primary School Breakfast Clubs
Allison Gardner contributed 1 speech (46 words) Monday 18th November 2024 - Commons Chamber Department for Education |
Allison Gardner speeches from: Oral Answers to Questions
Allison Gardner contributed 2 speeches (116 words) Thursday 14th November 2024 - Commons Chamber Department for Environment, Food and Rural Affairs |
Written Answers |
---|
Bovine Tuberculosis: Disease Control
Asked by: Allison Gardner (Labour - Stoke-on-Trent South) Monday 25th November 2024 Question to the Department for Environment, Food and Rural Affairs: To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to end badger culling. Answered by Daniel Zeichner - Minister of State (Department for Environment, Food and Rural Affairs) On 30 August, the Government announced the start of work on a comprehensive new strategy to drive down bovine TB rates to save cattle and farmers’ livelihoods and end the badger cull by the end of this parliament.
The Government will work with farmers, vets, scientists and conservationists to rapidly strengthen and deploy a range of disease control measures.
A key part of the strategy is the ongoing development of a cattle vaccine, which is at the forefront of innovative solutions to help eradicate this disease. Planning is advanced on the next stage of field trials which will assess cattleBCG vaccination and the companion DIVA skin test on a broader cohort of herds to further inform our collective planning for delivery. We are continuing to work at pace but will only deploy the vaccine and companion DIVA skin test when we have all the right steps in place.
The new strategy will mark a significant step-change in approach to tackling this devastating disease. It will consider a range of further measures including boosting cattle testing, reducing the spread of disease through cattle movements, and deploying badger vaccination on a wider, landscape scale. This will build on Professor Sir Charles Godfray’s 2018 independent strategy review.
Work to underpin the policy with robust science has begun immediately and includes a survey of the badger population for the first time in a decade, a wildlife surveillance programme, the launch of a Badger Vaccinator Field Force and a badger vaccination study to increase badger vaccination at pace to drive down TB rates and protect badgers. |
Calendar |
---|
Tuesday 26th November 2024 midnight Science, Innovation and Technology Committee - Private Meeting View calendar |
Tuesday 3rd December 2024 1:30 p.m. Science, Innovation and Technology Committee - Oral evidence Subject: Work of the Department for Science, Innovation and Technology At 2:30pm: Oral evidence Rt Hon Peter Kyle MP - Secretary of State at Department for Science, Innovation and Technology Sarah Munby - Permanent Secretary at Department for Science, Innovation and Technology View calendar |
Tuesday 17th December 2024 9 a.m. Science, Innovation and Technology Committee - Oral evidence Subject: Innovation showcase At 9:30am: Oral evidence Marie Labus - CEO at AMLo Biosciences At 9:45am: Oral evidence Professor David Lalloo - Vice-Chancellor at Liverpool School of Tropical Medicine Dr Lisa Stockdale - Senior Immunologist at The Jenner Institute At 10:20am: Oral evidence Professor Siddharthan Chandran - Director at The UK Dementia Research Institute Dr Simon Stott - Director of Research at Cure Parkinson's At 10:55am: Oral evidence Professor Ketan Patel - Chief Scientist at Cancer Research UK Dr Julie Torode - Director of Strategic Partnerships at Institute of Cancer Policy, Kings College London View calendar |
Select Committee Inquiry |
---|
20 Nov 2024
Social media, misinformation and harmful algorithms Science, Innovation and Technology Committee (Select) Not accepting submissions No description available |
4 Dec 2024
Innovation showcase Science, Innovation and Technology Committee (Select) Not accepting submissions Does the UK do enough to champion science and tech start-ups and scale-ups? The Committee aims to map out the landscape for the UK’s innovators, to give them a platform to tell their stories, and to identify what more the government and industry should do to support them. The cross-party Committee will hear from innovative companies and researchers through weekly “showcase sessions”, which will take place before its main evidence session each week. During this slot, showcase speakers will give a 5-minute presentation, covering their stories and their views on the wider operating environment, and whether they need more support from the Government and industry. The Committee will use their stories to explore the UK innovation landscape, including the regulatory framework and the investment and funding ecosystem; and to identify what the Government could do to improve it. |
6 Dec 2024
Innovation, growth and the regions Science, Innovation and Technology Committee (Select) Submit Evidence (by 13 Jan 2025) The Science, Innovation and Technology Select Committee is launching an inquiry into “Innovation, growth and the regions” to assess the role of the UK’s innovation ecosystem in achieving the Government’s mission to kickstart economic growth across the country. The inquiry will consider the role of structural factors—such as the tax system, regulatory requirements, and standards—in influencing the success of start-ups, spin-outs, and other innovation-focused enterprises. The Committee will assess the health of the country’s innovation ecosystem across the nations and regions. It will look at the interplay of local and national government policy, access to investment, research clusters, and infrastructure in fostering innovation and making the regions an engine for growth. It will explore how universities and businesses work together to commercialise research and to tackle obstacles such as funding and market access. It will evaluate the link between innovation and economic growth both regionally and nationally, drawing lessons from international comparators and considering the impact of regional clusters and hubs, including the Catapult network. |